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Inositol phosphates: Does IP4 run a protection racket?
Robin Irvine
The phosphorylation of IP3 by IP3 3-kinase leads to a
number of physiological events, most of which are
poorly understood. Recent findings about a hitherto
unsuspected action of the IP3 3-kinase product, IP4,
suggest that the evolution of IP3 3-kinase may have
even more far-reaching consequences than we thought.
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One could be forgiven for thinking that there is simply
no end to the things that evolution can do with inositol
(for recent reviews, see [1]). Results reported recently by
Hermosura et al. [2] have given us yet another example —
this time the subject is the functions of inositol 1,3,4,5-
tetrakisphosphate (IP4), which is made from the Ca2+-
mobilising second messenger inositol 1,4,5-trisphosphate
(IP3) by the action of the enzyme IP3 3-kinase. Our
current understanding is that IP3 3-kinase evolved com-
paratively recently [3,4] out of one branch of the diverse
family of inositol phosphate kinases [4–6], which have
been around since early eukaryotic days. Presumably IP3
3-kinase fulfilled the originally ‘simple’ function of remov-
ing IP3, but with the consequent appearance of a new
molecule, IP4, it was surely inevitable that this too would
be put to good use.
Hermosura et al. [2] suggest two distinct possible functions
for IP4. We have known for a long time that in vitro IP4
can protect IP3 against hydrolysis, because it has a 10-fold
higher affinity for the enzyme inositol phosphate 5-phos-
phatase [7], the major activity hydolysing both these inosi-
tol phosphates [8]. Hermosura et al. have found [2] that
indeed IP4 can do this in a patch-clamped cell, and as a
consequence it is effective in enhancing IP3’s ability to
activate store-operated Ca2+ entry (ICRAC). One could argue,
however, that superficially this does not make sense: if a
cell has to make IP4 from IP3, how can that lead to a net
gain in IP3? In a very ingenious experiment, Hermosura
et al. [2] have shown that there are circumstances where
this can be of great significance.
The inositol phosphate 5-phosphatase has a hundred-fold
lower Vmax for IP4 as compared with IP3 [8], so after cell
stimulation has ceased, IP4 will have a longer half life than
than IP3. Hermosura et al. [2] report data showing that the
IP4 that remains after a brief stimulation of a cell with an
IP3-generating agonist can ‘protect’ any new IP3 that is
formed by a subsequent stimulation. The IP4 thus serves
as a short-lived ‘memory’ that the cell has had a previous
episode of IP3 generation; you could say that it functions
as a sort of ‘co-incidence detector’.
This effect may be especially important in brain, where
IP3 3-kinase is found at very high levels in dendritic
spines [9,10]. There, IP3 3-kinase will be subject to
regulation [11] by that classic ‘coincidence-detecting’
enzyme [12], CaM kinase II, and this could make the
whole relationship between the two inositol phosphates
very complicated. For example, one could envisage cir-
cumstances where an activated IP3 kinase is busy remov-
ing IP3, but the consequent high levels of IP4 are
‘protecting’ the IP3 from hydolysis; which of these con-
flicting processes wins could depend on a complex set of
factors that may govern the lifetimes of the IP4 and of the
phosphorylated (activated) IP3 kinase.
The relationship between IP3 and IP4 also has a spatial
aspect, because of the different subcellular localisations
of the 5-phosphatase, which is attached to the plasma
membrane, versus the IP3 3-kinase, the B isoform of which
is located at the endoplasmic reticulum [13]. When we
also consider the additional possibility that the ratio of the
two enzymes — phosphatase and kinase — may differ
between tissues, it becomes rather daunting to consider
how subtle and complex such an apparently simple concept
of IP4 ‘protecting’ IP3 can be!
Hermosura et al. [2] also report a second property of IP4,
confirming an observation originally made in Putney’s lab
[14]. This is that IP4 can act as an antagonist at the IP3
receptor, an action that becomes significant if the ratio of
IP4 to IP3 is greater than about ten to one. The physiologi-
cal relevance of this phenomenon is not so clear, but it
may perhaps contribute to ‘sharpening up’ Ca2+ oscillations.
Ca2+ activation of the IP3 3-kinase during the ‘rising’
phase of an oscillation might generate a sufficiently high
IP4:IP3 ratio to temporarily ‘switch off’ IP3 receptors
— because of the antagonistic action of IP4 — and this
would help Ca2+ pools to re-load, thus speeding up the
‘down phase’ of the oscillation.
So, is this the whole story of the uses to which evolution has
put IP4? No it is not — life with inositides is never that
simple. The observation that IP4 can specifically and
directly activate Ca2+ channels in epithelial cells [15] and
neurons [16] clearly reveals an entirely different action of
IP4. Also, the large enhancement by IP4 of IP3-stimulated
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mobilisation and entry of Ca2+ in freshly isolated mouse
lacrimal cells [17,18] cannot be due to protection of IP3, as it
is observed using a non-metabolisable from of IP3 across an
enormous range (10–500 µM) of IP3 concentrations. The
same applies to the effect of IP4 to increase IP3-stimulated
Ca2+ mobilisation in permeabilised L-1210 cells, where pro-
tection of IP3 by IP4 has, specifically and beyond any rea-
sonable doubt, been eliminated as a contributory cause [19]. 
These last two actions of IP4 [17–19] clearly involve a
complex mechanism — not least because their ‘visibility’
is extremely dependent on experimental protocols (see
[20]) — and currently the most likely explanation is that
IP4 somehow regulates the location and structure of the
endoplasmic reticulum, which functions as the major IP3-
mobilisable Ca2+ store [20]. There is evidence that this
action of IP4 involves GAP1IP4BP [21] — currently the
most promising candidate protein to be an IP4 receptor —
and the close homology between GAP1IP4BP and another
protein, GAP1m, which is almost certainly a receptor for
the inositol lipid phosphatidylinositol 3,4,5-trisphosphate
(PIP3) [22], gives us an intriguing clue about the possible
evolution of this particular aspect of IP4’s functions. The
hydrophilic headgroup of PIP3 is in fact IP4, so any PIP3
‘receptor’ should specifically recognise IP4, and indeed
most do in vitro [23]. So, now we know that the evolution
of PIP3 probably preceded that of IP4 [3], it is an appeal-
ing scenario to imagine that this action of IP4 evolved out
of a function of PIP3 connected with the organisation and
dynamics of the endomembrane system, especially near
the plasma membrane (the principal site of PIP3 synthesis
and of GAP1IP4BP [24]).
Whatever the validity of this particular idea, it seems
inescapable that there are multiple functions of IP4
(Figure 1). Moreover, we must remember that there are at
least two other consequences of the action of IP3 3-kinase.
Firstly, the immediate breakdown product of IP4, inosi-
tol 1,3,4-trisphosphate, has been shown [25] to be the
main regulator of the levels of inositol 3,4,5,6-tetrakispho-
sphate, itself a second messenger that controls chloride
efflux [26]. And secondly, IP3 3-kinase may be the first
step in a receptor-regulated synthesis pathway leading to
the ‘higher’ inositol phosphates, such IP5, IP6 and —
perhaps the most surprising inositol phosphate ‘prolifera-
tion’ of all — IP7 and IP8 [26].
At this point we begin to realise that the evolution of IP3
3-kinase has had a truly remarkable number of knock-on
effects on cell physiology (Figure 1), and this all becomes
rather reminiscent of that other 3-phosphorylation of the
inositol ring, the story of the inositol lipid 3-kinases. Once
the first phosphatidylinositol 3-kinase evolved, it led to a
rapid proliferation of 3-phosphorylated inositol lipids,
which we now know fulfil a truly awesome number of
physiological functions (see several chapters in [1]). It
seems that the appearance of IP3 3-kinase led to a smaller,
but nevertheless still impressive, set of interrelated cellular
consequences.
Finally, if we consider inositol phosphates in general, this
is probably just the tip of the iceberg — consider, for
example, the recent implication of inositol phosphates in
regulating some nuclear functions [6]. The 1990s saw a
remarkable proliferation of inositol lipids and their actions,
Figure 1
A diagrammatic representation of the various
consequences of the 3-phosphorylation of IP3
discussed in the text. Open arrows represent
metabolic routes, and wavy red arrows
indicate regulatory influences. These
regulatory influences are are: (1) the inhibition
of IP3 hydrolysis by IP4; (2) the inhibition of
IP3-stimulated Ca2+ mobilisation by high
concentrations of IP4; (3) the positive
influence of IP4 on Ca2+ mobilisation and
entry by a complex, incompletely understood
mechanism discussed in the text; (4) the
direct action of IP4 on some Ca2+ channels;
(5) the inhibition of 3,4,5,6-IP4 1-kinase by
(1,3,4)IP3.
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and the recent excitement in the inositol phosphate field
alluded to here leads one to wonder whether we are set for
another explosion in the 2000s, but this time in the ‘water-
soluble’ phase of inositide function?
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